NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
22/04/2025
Voltar para busca
Dado oficial do USPTO
ROSLINCT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ROSLINCT
ST13
US500000097913008Classe
35, 40, 41, 42, 44
Pedido
97913008
Registro
7771028
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
22
Atualização mais recente
23/04/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 40, 41, 42, 44
Data de depósito
28/04/2023
Data de registro
22/04/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
22/04/2025
Última transação
23/04/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
04/08/2015
Primeiro uso no comércio
06/05/2023
Código do desenho
4
Tipo de titular
99
Localização do titular
Edinburgh, GB
Examinador
WUDARSKY, MINDY
Unidade examinadora
M80
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Roslin Cell Therapies Limited
Representantes
Benjamin P. Harbuck DENTONS US LLP
Classificação técnica
Classes Nice
Classe 35Classe 40Classe 41Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Business informationconsultancy and management services in the fields of designingbuildingtesting and validating processes and systems for use in cell therapy and gene therapy services; business consultation services in the nature of technology transfer advice and management in the fields of cell therapy and gene therapy; advertisingmarketing and promotional services in the fields of cell therapy and gene therapy; informationadvisory and consultancy services related to the aforesaid
Classe 40
Contract manufacturing of pharmaceutical and biopharmaceutical products in the fields of cell therapy and gene therapy; contract manufacturing in the fields of cell therapy and gene therapy; custom manufacturing of pharmaceutical and biopharmaceutical products in the fields of cell therapy and gene therapy; custom manufacturing in the fields of cell therapy and gene therapy; custom fabrication and production of cells for others; manufacturing process consulting in the fields of cell therapy and gene therapy; informationadvisory and consultancy services related to the aforesaid
Classe 41
Education and training servicesclassesseminarstutorialsconferences and workshops in the fields of cell therapy and gene therapy; provision of online educationtraining and teaching servicesclassesnon-downloadable webinars and tutorials in the fields of cell therapy and gene therapy; arrangingorganising and conducting of colloquiumsconferencescongressesseminars and symposiums in the fields of cell therapy and gene therapy; publication of booksscientific papers and texts in the fields of cell therapy and gene therapy; informationadvisory and consultancy services related to the aforesaid
Classe 42
Scientific researchdevelopment and testing services in the fields of cell therapy and gene therapy; research and development of new products for others in the fields of cell therapy and gene therapy; pharmaceutical and biopharmaceutical research and development services in the fields of cell therapy and gene therapy; scientific consultancy services in the fields of designingbuildingtesting and validating processes and systems for use in cell therapy and gene therapy services; design and development of computer hardware and software in the biopharmaceuticalcell therapy and gene therapy fields; development of computer databases in the biopharmaceuticalcell therapy and gene therapy fields; scientific development of custom assays for cell therapy and gene therapy; stem cell research services; informationadvisory and consultancy services related to the aforesaid
Classe 44
Medical services relating to the removaltreatment and processing of stem cells; medical servicesstem cell therapy services; medical servicesgene therapy services; stem cell bank servicesstem cell storage; informationadvisory and consultancy services related to the aforesaid
Publicações
Histórico de despachos e eventos da marca no USPTO.
22 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
22/04/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/04/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/04/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
14/03/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
13/03/2025
IUAF
USE AMENDMENT FILED
09/01/2025
EISU
TEAS STATEMENT OF USE RECEIVED
09/01/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/07/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/05/2024
PUBO
PUBLISHED FOR OPPOSITION
14/05/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
24/04/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/04/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/04/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/04/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/04/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
30/01/2024
GNRT
NON-FINAL ACTION E-MAILED
30/01/2024
CNRT
NON-FINAL ACTION WRITTEN
30/01/2024
DOCK
ASSIGNED TO EXAMINER
25/01/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
27/05/2023
NWAP
NEW APPLICATION ENTERED
02/05/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ROSLINCT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.